Cite
Fidaxomicin for Clostridium difficile-associated diarrhoea: epidemiological method for estimation of warranted price
MLA
Jennifer M. Schmidt, et al. “Fidaxomicin for Clostridium Difficile-Associated Diarrhoea: Epidemiological Method for Estimation of Warranted Price.” Clinical Drug Investigation, vol. 32, no. 8, June 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....45cb4a3941aa80bbce43f11556181c7f&authtype=sso&custid=ns315887.
APA
Jennifer M. Schmidt, Kurt A. Bowen, Ambartsum M. Oganov, David A. Sclar, Leigh V. Castillo, & Linda M. Robison. (2012). Fidaxomicin for Clostridium difficile-associated diarrhoea: epidemiological method for estimation of warranted price. Clinical Drug Investigation, 32(8).
Chicago
Jennifer M. Schmidt, Kurt A. Bowen, Ambartsum M. Oganov, David A. Sclar, Leigh V. Castillo, and Linda M. Robison. 2012. “Fidaxomicin for Clostridium Difficile-Associated Diarrhoea: Epidemiological Method for Estimation of Warranted Price.” Clinical Drug Investigation 32 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....45cb4a3941aa80bbce43f11556181c7f&authtype=sso&custid=ns315887.